Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with a disease or disorder, such as those associated with dysbiosis of a gastrointestinal tract. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.
A61K 39/395 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided are defined bacterial compositions for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for populating the gastrointestinal tract of a subject. Provided also are bacterial formulations for oral or gastric administration to a mammalian subject in an effective amount for prevention or treatment of a gastrointestinal disease, disorder or condition.
Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided herein are bacterial compositions that are useful for treating and/or preventing a chronic liver disease, neutropenia, and/or a disease or disorder associated with a solid organ transplantation. In some aspects, treating and/or preventing comprises treating an infection complication due to a chronic liver disease, neutropenia, and/or a solid organ transplantation. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61K 31/58 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes contenant des hétérocycles, p. ex. danazol, stanozolol, pancuronium ou digitogénine
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
10.
USE OF IMMUNOTHERAPY AND MICROBIOME MODULATION TO TREAT CANCER
Provided herein are methods and compositions for the treatment of various types of cancers by modulating the microbiome to effect or enhance the efficacy of immunotherapy. Also provided herein are methods of determining a response to an immunotherapy by identifying if a subject has a favorable microbial profile. Further provided herein are methods of determining a donor whose feces are useful for fecal matter transfer.
Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with a disease or disorder, such as those associated with immune suppression, including infections and/or GvHD, for example, in HSCT subjects. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
13.
Synergistic bacterial compositions and methods of production and use thereof
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with a disease or disorder, such as those associated with dysbiosis of a gastrointestinal tract. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.
Provided herein are methods and compositions for the treatment of various types of cancers by modulating the microbiome to effect or enhance the efficacy of immunotherapy. Also provided herein are methods of determining a response to an immunotherapy by identifying if a subject has a favorable microbial profile. Further provided herein are methods of determining a donor whose feces are useful for fecal matter transfer.
A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
C12Q 1/04 - Détermination de la présence ou du type de micro-organismeEmploi de milieux sélectifs pour tester des antibiotiques ou des bactéricidesCompositions à cet effet contenant un indicateur chimique
A61K 35/747 - Lactobacilles, p. ex. L. acidophilus ou L. brevis
C12Q 1/689 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour la détection ou l’identification d’organismes pour les bactéries
16.
Synergistic bacterial compositions and methods of production and use thereof
Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Compositions for methods of preventing or reducing pathogenic bacterial growth, proliferation, and/or colonization are described containing one or more types of non-pathogenic bacteria to be introduced into the gastrointestinal tract and effectively compete with pathogenic bacteria for monomeric or polymeric carbohydrate nutrients, and/or amino acid nutrients, and/or vitamin nutrients.
Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with a disease or disorder, such as those associated with immune suppression, including infections and/or GvHD, for example, in HSCT subjects. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A23L 31/00 - Extraits ou préparations comestibles de champignonsLeur préparation ou leur traitement
A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
19.
COMPOSITIONS FOR STABILIZING BACTERIA AND USES THEREOF
Provided herein are compositions and formulations that are useful for stabilizing one or more bacteria (e.g., through drying). Methods of stabilizing the one or more bacteria are also disclosed.
Our client, Seres Therapeutics, has asked us to file a new provisional application related to bacterial compositions and the use of such compositions for the treatment of inflammatory bowel disease.
A61K 35/742 - Bactéries sporulées, p. ex. Bacillus coagulans, Bacillus subtilis, clostridium ou Lactobacillus sporogenes
A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
A61P 37/06 - Immunosuppresseurs, p. ex. médicaments pour le traitement du rejet de greffe
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with a disease or disorder, such as those associated with dysbiosis of a gastrointestinal tract. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61K 31/58 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes contenant des hétérocycles, p. ex. danazol, stanozolol, pancuronium ou digitogénine
26.
Compositions and methods for treating antibiotic resistance
Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided herein are compositions and formulations that are useful for stabilizing one or more bacteria (e.g., through drying). Methods of stabilizing the one or more bacteria are also disclosed.
A01N 63/02 - Substances produites par, ou obtenues à partir de micro-organismes ou d'animaux
A23K 10/16 - Ajout de micro-organismes ou de leurs produits d’extraction, p. ex. de protéines provenant d’organismes unicellulaires, à des compositions de produits alimentaires
A23K 40/30 - Mise en forme ou traitement des produits alimentaires pour animaux par encapsulationMise en forme ou traitement des produits alimentaires pour animaux par revêtement
Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with a disease or disorder, such as those associated with dysbiosis of a gastrointestinal tract. The bacterial compositions disclosed herein are designed to exhibit one or more functional features that are useful for the treatment of such diseases and disorders.
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided herein are bacterial compositions that are useful for treating and preventing complications and side effects associated with an inflammatory bowel disease.
A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (USA)
Inventeur(s)
Wortman, Jennifer
Diao, Liyang
Desjardins, Christopher
Marnellos, Georgios
Henn, Matthew
Wargo, Jennifer
Gopalakrishnan, Vancheswaran
Abrégé
Methods are provided for identifying donors of fecal matter that can improve a subject's response to a checkpoint inhibitor in the treatment of cancer. Methods and compositions are also provided for using donated fecal matter in the treatment of cancer.
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Medical research; research and development in the pharmaceutical and biotechnology fields; scientific research and development services relating to foods and dietary supplements; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
(1) Medical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided are compositions containing combinations of bacteria useful for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract, or other niche of a mammalian subject, and methods for use thereof, in particular for the treatment, inhibition, or prevention of immune disorders such as allergies and asthma.
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
A61K 35/00 - Préparations médicinales contenant des substances ou leurs produits de réaction de constitution non déterminée
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Dietary and nutritional supplements; nutritional food additives for medical purposes; baby food; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; nutritionally fortified beverages for medical purposes; infant formula; nutritional food bars for meal replacement and for medicinal purposes; pharmaceuticals used to maintain health or restore health to an animal subject via treatment of a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to an animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for veterinary purposes.
43.
Compositions and methods for inhibition of pathogenic bacterial growth
Compositions for methods of preventing or reducing pathogenic bacterial growth, proliferation, and/or colonization are described containing one or more types of non-pathogenic bacteria to be introduced into the gastrointestinal tract and effectively compete with pathogenic bacteria for monomeric or polymeric carbohydrate nutrients, and/or amino acid nutrients, and/or vitamin nutrients.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical purposes; pharmaceuticals and biological preparations used to prevent conditions resulting from a disturbed microbial community.
Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
Provided are defined bacterial compositions for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for populating the gastrointestinal tract of a subject. Provided also are bacterial formulations for oral or gastric administration to a mammalian subject in an effective amount for prevention or treatment of a gastrointestinal disease, disorder or condition.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceuticals to treat a disturbed microbial community in a human or an animal subject; dietary and nutritional supplements for general health and well-being, nutritional food additives for medical purposes, namely, probiotic microorganisms for general health and well-being; baby food; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; nutritionally fortified non-alcoholic beverages, with live microorganisms, for promoting a healthy gut microbiome; infant formula; biological preparations to treat a disturbed microbial community in a human or an animal subject; cultures and preparations of microorganisms for medical and veterinary purposes, namely, for promoting a healthy gut microbiome; nutritional food bars for meal replacement and for medicinal purposes for promoting a healthy gut microbiome
05 - Produits pharmaceutiques, vétérinaires et hygièniques
32 - Bières; boissons non alcoolisées
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Dietary and nutritional supplements, nutritional food additives for medical purposes; baby food; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; nutritionally fortified beverages; infant formula; nutritional food bars for meal replacement and for medicinal purposes; pharmaceuticals used to maintain health or restore health to an animal subject via treatment of a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for veterinary purposes; cultures and preparations of microorganisms for medical purposes. Non-fruit and non-vegetable based syrups and other preparations for making non-alcoholic beverages. Medical research; research and development in the pharmaceutical and biotechnology fields; scientific research and development services relating to foods and dietary supplements; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto. Consulting services in the fields of diagnostic medical testing and nutrition; and/or medical diagnostic testing, monitoring, and reporting services.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
32 - Bières; boissons non alcoolisées
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
(1) Dietary and nutritional supplements for general health and well-being, nutritional food additives for medical purposes in the nature of microorganisms, baby food; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; nutritionally fortified non-alcoholic beverages, with live microorganisms, for promoting a healthy gastrointestinal microbiome; infant formula; nutritional food bars for meal replacement and for medicinal purposes, namely, for promoting a healthy gut microbiome; veterinary pharmaceuticals to treat a disturbed microbial community in an animal subject; veterinary biological preparations to treat a disturbed microbial community in an animal subject; cultures and preparations of microorganisms for veterinary purposes, namely, for promoting a healthy gastrointestinal microbiome, the restoration of a dysbiotic microbiome to a healthy state, prevention of a dysbiosis.
(2) Cultures and preparations of microorganisms for medical purposes, namely, for promoting a healthy gastrointestinal microbiome, the restoration of a dysbiotic microbiome to a healthy state, prevention of a dysbiosis.
(3) Non-fruit and non-vegetable based syrups for making non-alcoholic beverages. (1) Medical research; research and development in the pharmaceutical and biotechnology fields; scientific research and development services relating to foods and dietary supplements; providing reagent sample testing and diagnostic services for others in the fields of medical science and research related thereto.
(2) Consulting services in the fields of diagnostic medical testing and nutrition; medical diagnostic testing, monitoring, and reporting services.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical purposes
51.
Synergistic bacterial compositions and methods of production and use thereof
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided are compositions containing combinations of bacteria useful for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract, or other niche of a mammalian subject, and methods for use thereof, in particular for the treatment, inhibition, or prevention of immune disorders such as allergies and asthma.
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
05 - Produits pharmaceutiques, vétérinaires et hygièniques
32 - Bières; boissons non alcoolisées
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
(1) Dietary and nutritional supplements for general health and well-being, nutritional food additives for medical purposes in the nature of microorganisms; baby food; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; Non-fruit and non-vegetable based syrups for making non-alcoholic beverages. (1) Medical research; research and development in the pharmaceutical and biotechnology fields; scientific research and development services relating to foods and dietary supplements; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
05 - Produits pharmaceutiques, vétérinaires et hygièniques
32 - Bières; boissons non alcoolisées
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Dietary and nutritional supplements, nutritional food additives for medical purposes; baby food; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial. Non-fruit and non-vegetable based syrups and other preparations for making beverages. Medical research; research and development in the pharmaceutical and biotechnology fields; scientific research and development services relating to foods and dietary supplements; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto.
55.
SYNERGISTIC BACTERIAL COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF
Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, cultures and preparations of microorganisms for medical purposes
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community, cultures and preparations of microorganisms for medical and veterinary purposes
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community, cultures and preparations of microorganisms for medical and veterinary purposes.
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Medical research; research and development in the pharmaceutical and biotechnology fields; scientific research and development services relating to foods and dietary supplements; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals used to maintain health or restore health to a human subject via treatment of a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject via treatment of a disturbed microbial community, cultures and preparations of microorganisms for medical purposes
61.
METHODS FOR PATHOGEN DETECTION AND ENRICHMENT FROM MATERIALS AND COMPOSITIONS
Provided are methods and compositions for characterization of bacterial compositions for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and the resulting characterized compositions. Provided are methods of characterizing bacterial compositions including subjecting the compositions to various detecting processes.
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
C12Q 1/02 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des micro-organismes viables
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
Provided are therapeutic compositions containing combinations of bacteria, for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for use thereof.
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
Methods and compositions for populating the gastrointestinal tract of a subject are described. Methods include administering to a subject a therapeutic composition comprising a purified population of spore-forming bacteria produced by providing a fecal material and subjecting the material to a treatment step resulting in purification of spore- forming bacteria. Methods include administering an amount effective to engraft and/or augment in the gastrointestinal tract in order to treat or prevent a dysbiosis in the mammalian subject.
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
65.
COMPOSITIONS AND METHODS FOR INHIBITION OF PATHOGENIC BACTERIAL GROWTH
Compositions for methods of preventing or reducing pathogenic bacterial growth, proliferation, and/or colonization are described containing one or more types of non-pathogenic bacteria to be introduced into the gastrointestinal tract and effectively compete with pathogenic bacteria for monomeric or polymeric carbohydrate nutrients, and/or amino acid nutrients, and/or vitamin nutrients.
Provided are defined bacterial compositions for the maintenance or restoration of a healthy microbiota in the gastrointestinal tract of a mammalian subject, and methods for populating the gastrointestinal tract of a subject. Provided also are bacterial formulations for oral or gastric administration to a mammalian subject in an effective amount for prevention or treatment of a gastrointestinal disease, disorder or condition.
C12N 1/00 - Micro-organismes, p. ex. protozoairesCompositions les contenantProcédés de culture ou de conservation de micro-organismes, ou de compositions les contenantProcédés de préparation ou d'isolement d'une composition contenant un micro-organismeLeurs milieux de culture
67.
Synergistic bacterial compositions and methods of production and use thereof
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
Provided are therapeutic compositions containing ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
69.
Synergistic bacterial compositions and methods of production and use thereof
Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Therapeutic agents and consumer products in the nature of microorganisms for medical use used to restore health to a human or animal subject via treatment of a disturbed microbial community. Research and development of therapeutics and consumer products consisting of designed ecologies of microorganisms, combinations of microorganisms, or individually selected microorganisms which restore health to a mammalian subject with a disturbed human microbial community.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Therapeutic agents and consumer products in the nature of microorganisms for medical use used to restore health to a human subject via treatment of a disturbed microbial community
42 - Services scientifiques, technologiques et industriels, recherche et conception
Produits et services
Development of pharmaceuticals, diagnostics, food additives, dietary supplements, medical foods, foods for special dietary use and foods, namely, development of preparations for the diagnosis and treatment of human diseases and for maintaining and restoring health
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
Pharmaceuticals in the nature of microorganisms for medical use, used to maintain health or restore health to a human subject via treatment of a disturbed microbial community
